Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-09-05
1992-04-07
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142342, 514243, 540599, 544 584, 544112, 544184, 544236, 544267, 544270, 544264, 544277, 544350, 546118, A61K 3153, C07D48704
Patent
active
051028808
ABSTRACT:
Substituted Imidazo-fused 6-membered heterocycles of structural formula: ##STR1## wherein A, B, C, and D are independently carbon atoms or nitrogren atoms are angiotensin II antagonists useful in the treatment of hypertension and congestive heart failure.
REFERENCES:
patent: 4880804 (1989-11-01), Carini et al.
Chakravarty Prasun K.
Greenlee William J.
Mantlo Nathan B.
Patchett Arthur A.
Walsh Thomas F.
Dentz Bernard
DiPrima Joseph F.
Merck & Co. , Inc.
Nicholson William H.
LandOfFree
Substituted imidazo-fused 6-membered heterocycles as angiotensin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted imidazo-fused 6-membered heterocycles as angiotensin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazo-fused 6-membered heterocycles as angiotensin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1895449